Drug repositioning for anti-tuberculosis drugs: an in silico polypharmacology approach

被引：0
|
作者：
Sita Sirisha Madugula
Selvaraman Nagamani
Esther Jamir
Lipsa Priyadarsinee
G. Narahari Sastry
机构：
[1] CSIR-Indian Institute of Chemical Technology,Centre for Molecular Modelling
[2] Academy of Scientific and Innovative Research (AcSIR),Advanced Computation and Data Sciences Division
[3] CSIR – North East Institute of Science and Technology,undefined
来源：
Molecular Diversity | 2022年 / 26卷
关键词：
targets; Drug repositioning; Polypharmacology; Virtual screening; PASS;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1675 / 1695
页数：20
相关论文
共 50 条
  • [1] Drug repositioning for anti-tuberculosis drugs: an in silico polypharmacology approach
    Madugula, Sita Sirisha
    Nagamani, Selvaraman
    Jamir, Esther
    Priyadarsinee, Lipsa
    Sastry, G. Narahari
    MOLECULAR DIVERSITY, 2022, 26 (03) : 1675 - 1695
  • [2] Anti-tuberculosis potential of bruceine: An in silico approach
    Akshata, C. R.
    Murugan, E.
    Harichandran, G.
    INDIAN JOURNAL OF CHEMICAL TECHNOLOGY, 2022, 29 (06) : 782 - 787
  • [3] Drug-Resistant Tuberculosis and Group 5 Anti-Tuberculosis Drugs
    Shokouhi, Shervin
    Darazam, Ilad Alavi
    ARCHIVES OF PEDIATRIC INFECTIOUS DISEASES, 2015, 3 (01):
  • [4] GES Polypharmacology Fingerprints: A Novel Approach for Drug Repositioning
    Perez-Nueno, Violeta I.
    Karaboga, Arnaud S.
    Souchet, Michel
    Ritchie, David W.
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2014, 54 (03) : 720 - 734
  • [5] ITRACONAZOLE AND ANTI-TUBERCULOSIS DRUGS
    BLOMLEY, M
    TEARE, EL
    DEBELDER, A
    THWAY, Y
    WESTON, M
    LANCET, 1990, 336 (8725): : 1255 - 1255
  • [6] HEPATOTOXICITY BY ANTI-TUBERCULOSIS DRUGS
    Yanez Elena, Sanchez
    Maria Rosa, Mora Santiago
    Jose Manuel, Fernandez Ovies
    ATENCION FARMACEUTICA, 2011, 13 (06): : 338 - +
  • [7] TESTING ANTI-TUBERCULOSIS DRUGS
    不详
    BMJ-BRITISH MEDICAL JOURNAL, 1952, 2 (4799): : 1402 - 1403
  • [8] Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs
    Kuhlin, Johanna
    Sturkenboom, Marieke G. G.
    Ghimire, Samiksha
    Margineanu, Ioana
    van den Elsen, Simone H. J.
    Simbar, Noviana
    Akkerman, Onno W.
    Jongedijk, Erwin M.
    Koster, Remco A.
    Bruchfeld, Judith
    Touw, Daan J.
    Alffenaar, Jan-Willem C.
    CLINICAL MASS SPECTROMETRY, 2019, 14 : 34 - 45
  • [9] The epidemiology of tuberculosis and resistance to anti-tuberculosis drugs
    Khaled, NA
    Enarson, D
    Billo, N
    REVUE DES MALADIES RESPIRATOIRES, 1997, 14 : S8 - S18
  • [10] Anti-tuberculosis therapy: Urgency for new drugs and integrative approach
    Jena, Lingaraja
    Harinath, Bhaskar C.
    BIOMEDICAL AND BIOTECHNOLOGY RESEARCH JOURNAL, 2018, 2 (01): : 16 - 19
12345